RecruitingNCT05738525

Comparative Study of Prognosis and QOL Between APD-RPM and CAPD

Comparative Study of Automated Peritoneal Dialysis With Remote Patient Management And Continuous Ambulatory Peritoneal Dialysis on the Prognosis and QOL in Peritoneal Dialysis Patients

Sponsor

Chinese PLA General Hospital

Enrollment

750 participants

Start Date

Jun 1, 2023

Study Type

OBSERVATIONAL

Conditions

End Stage Renal Disease

Summary

This is an observational, multicenter, parallel control study, planning to enroll 750 eligible patients to receive automated peritoneal dialysis with remote patient management (APD-RPM) and continuous ambulatory peritoneal dialysis (CAPD). Patients will attend follow-up every 12 ± 1 weeks for a total of 156 weeks. This study aims to compare the effects of APD-RPM and CAPD treatment on the prognosis and quality of life.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study compares two types of peritoneal dialysis (a form of home kidney dialysis that uses the belly lining to filter waste) — a machine-assisted nighttime method versus a manual daytime method — in patients with kidney failure who remove fluid and waste very quickly through their peritoneum. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with end-stage kidney (renal) disease - You are already on peritoneal dialysis for at least 3 months - Tests show your peritoneum (belly lining) transfers waste rapidly - You are able to manage dialysis at home **You may NOT be eligible if...** - You are planning to get a kidney transplant within 3 years - You also need hemodialysis (machine dialysis) - You are allergic to peritoneal dialysis fluid - You have severe heart conditions, liver problems, or active cancer - You are pregnant or breastfeeding - You have a history of alcohol or drug abuse - You have intellectual disability or serious mental illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAPD-RPM

APD mode is recommended but not limited to continuous circulating peritoneal dialysis (CCPD); (2) Dialysis dose ranges from 5 to 10 liters per day and depends on previous APD prescription and dialysis adequacy; (3) Glucose concentration starts from low concentration (1.5%) and depends on previous dialysis prescription. Remote monitoring includes dynamic changes of the overall treatment situation, warning or any abnormal notes, and drainage, retention and duration of APD per day.